JP2006515625A5 - - Google Patents

Download PDF

Info

Publication number
JP2006515625A5
JP2006515625A5 JP2006500944A JP2006500944A JP2006515625A5 JP 2006515625 A5 JP2006515625 A5 JP 2006515625A5 JP 2006500944 A JP2006500944 A JP 2006500944A JP 2006500944 A JP2006500944 A JP 2006500944A JP 2006515625 A5 JP2006515625 A5 JP 2006515625A5
Authority
JP
Japan
Prior art keywords
effective amount
medicament
long
medicament according
acting insulin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006500944A
Other languages
English (en)
Japanese (ja)
Other versions
JP5389325B2 (ja
JP2006515625A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/000879 external-priority patent/WO2004064862A1/en
Publication of JP2006515625A publication Critical patent/JP2006515625A/ja
Publication of JP2006515625A5 publication Critical patent/JP2006515625A5/ja
Application granted granted Critical
Publication of JP5389325B2 publication Critical patent/JP5389325B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2006500944A 2003-01-14 2004-01-14 前糖尿病患者および２型糖尿病患者における心血管系の罹病率および死亡率を低下させるための長時間作用型インスリン Expired - Lifetime JP5389325B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US43994103P 2003-01-14 2003-01-14
US60/439,941 2003-01-14
PCT/US2004/000879 WO2004064862A1 (en) 2003-01-14 2004-01-14 Long acting insulin for reducing cardiovascular morbidity and mortality in prediabetic patients and patients with type 2 diabetes

Publications (3)

Publication Number Publication Date
JP2006515625A JP2006515625A (ja) 2006-06-01
JP2006515625A5 true JP2006515625A5 (https=) 2007-03-01
JP5389325B2 JP5389325B2 (ja) 2014-01-15

Family

ID=23746761

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006500944A Expired - Lifetime JP5389325B2 (ja) 2003-01-14 2004-01-14 前糖尿病患者および２型糖尿病患者における心血管系の罹病率および死亡率を低下させるための長時間作用型インスリン

Country Status (16)

Country Link
US (4) US7405196B2 (https=)
EP (2) EP1589991A1 (https=)
JP (1) JP5389325B2 (https=)
AU (2) AU2004206829B2 (https=)
BR (1) BRPI0406499A (https=)
CA (1) CA2512820C (https=)
CY (1) CY1118738T1 (https=)
DK (1) DK2596800T3 (https=)
ES (1) ES2604359T3 (https=)
GB (1) GB0309154D0 (https=)
HU (1) HUE031892T2 (https=)
IL (3) IL169697A (https=)
MX (1) MXPA05007470A (https=)
PT (1) PT2596800T (https=)
SI (1) SI2596800T1 (https=)
WO (1) WO2004064862A1 (https=)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
US6923175B2 (en) 2002-03-20 2005-08-02 Mannkind Corporation Inhalation apparatus
DE602004021603D1 (de) * 2003-07-25 2009-07-30 Conjuchem Biotechnologies Inc Insulinderivative mit langanhaltender wirkung und verfahren zu deren herstellung
ATE486064T1 (de) 2004-08-20 2010-11-15 Mannkind Corp Katalyse der diketopiperazinsynthese
KR20130066695A (ko) 2004-08-23 2013-06-20 맨카인드 코포레이션 약물 전달용 디케토피페라진염, 디케토모르포린염 또는 디케토디옥산염
MX373000B (es) 2005-09-14 2020-05-21 Mannkind Corp Metodo para formulacion de farmaco basado en el aumento de la afinidad de agentes activos hacia las superficies de microparticulas cristalinas.
EP1986679B1 (en) 2006-02-22 2017-10-25 MannKind Corporation A method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
CN101827626B (zh) 2008-06-13 2015-03-18 曼金德公司 干粉吸入器和用于药物输送的系统
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
ES2421385T3 (es) 2008-06-20 2013-09-02 Mannkind Corp Aparato interactivo y procedimiento para establecer el perfil, en tiempo real, de esfuerzos de inhalación
TWI532497B (zh) 2008-08-11 2016-05-11 曼凱公司 超快起作用胰島素之用途
CN102256618A (zh) 2008-10-17 2011-11-23 赛诺菲-安万特德国有限公司 胰岛素和glp-1激动剂的组合
US10437962B2 (en) 2008-12-23 2019-10-08 Roche Diabetes Care Inc Status reporting of a structured collection procedure
US9918635B2 (en) 2008-12-23 2018-03-20 Roche Diabetes Care, Inc. Systems and methods for optimizing insulin dosage
US10456036B2 (en) * 2008-12-23 2019-10-29 Roche Diabetes Care, Inc. Structured tailoring
US8849458B2 (en) * 2008-12-23 2014-09-30 Roche Diagnostics Operations, Inc. Collection device with selective display of test results, method and computer program product thereof
CN102265280A (zh) * 2008-12-23 2011-11-30 霍夫曼-拉罗奇有限公司 用于在收集设备上运行的结构化收集过程的实现、执行、数据收集和数据分析的管理方法和系统
US9117015B2 (en) 2008-12-23 2015-08-25 Roche Diagnostics Operations, Inc. Management method and system for implementation, execution, data collection, and data analysis of a structured collection procedure which runs on a collection device
US20120011125A1 (en) 2008-12-23 2012-01-12 Roche Diagnostics Operations, Inc. Management method and system for implementation, execution, data collection, and data analysis of a structured collection procedure which runs on a collection device
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
DK2405963T3 (da) 2009-03-11 2013-12-16 Mannkind Corp Apparat, system og fremgangsmåde til at måle modstand i en inhalator
KR102584844B1 (ko) 2009-06-12 2023-10-04 맨카인드 코포레이션 한정된 비표면적을 갖는 디케토피페라진 마이크로입자
PL2451437T3 (pl) 2009-07-06 2017-05-31 Sanofi-Aventis Deutschland Gmbh Wodne preparaty insuliny zawierające metioninę
CA2778698A1 (en) 2009-11-03 2011-05-12 Mannkind Corporation An apparatus and method for simulating inhalation efforts
TR201809460T4 (tr) 2009-11-13 2018-07-23 Sanofi Aventis Deutschland Bir GLP- 1-agonisti, bir insülin ve metiyonin içeren farmasötik bileşim.
NZ599847A (en) 2009-11-13 2013-09-27 Sanofi Aventis Deutschland Pharmaceutical composition comprising a glp-1 agonist and methionine
AU2011202239C1 (en) 2010-05-19 2017-03-16 Sanofi Long-acting formulations of insulins
US8532933B2 (en) 2010-06-18 2013-09-10 Roche Diagnostics Operations, Inc. Insulin optimization systems and testing methods with adjusted exit criterion accounting for system noise associated with biomarkers
CN102985125A (zh) 2010-06-21 2013-03-20 曼金德公司 干粉药物输送系统和方法
WO2012028172A1 (en) 2010-08-30 2012-03-08 Sanofi-Aventis Deutschland Gmbh Use of ave0010 for the manufacture of a medicament for the treatment of diabetes mellitus type 2
US20120173151A1 (en) 2010-12-29 2012-07-05 Roche Diagnostics Operations, Inc. Methods of assessing diabetes treatment protocols based on protocol complexity levels and patient proficiency levels
SG194034A1 (en) 2011-04-01 2013-11-29 Mannkind Corp Blister package for pharmaceutical cartridges
US8755938B2 (en) 2011-05-13 2014-06-17 Roche Diagnostics Operations, Inc. Systems and methods for handling unacceptable values in structured collection protocols
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
US8766803B2 (en) 2011-05-13 2014-07-01 Roche Diagnostics Operations, Inc. Dynamic data collection
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
AR087693A1 (es) 2011-08-29 2014-04-09 Sanofi Aventis Deutschland Combinacion farmaceutica para uso en el control glucemico en pacientes con diabetes de tipo 2
TWI559929B (en) 2011-09-01 2016-12-01 Sanofi Aventis Deutschland Pharmaceutical composition for use in the treatment of a neurodegenerative disease
MX2014004983A (es) 2011-10-24 2014-09-22 Mannkid Corp Metodos y composiciones para tratar dolor.
EP2785366A1 (en) * 2011-12-01 2014-10-08 Sanofi Insulin glargine versus metformin for the first-line treatment of early type 2 diabetes
WO2013144273A1 (en) * 2012-03-28 2013-10-03 Sanofi Basal insulin therapy
KR102264177B1 (ko) 2012-07-12 2021-06-11 맨카인드 코포레이션 건조 분말 약물 전달 시스템 및 방법
WO2014066856A1 (en) 2012-10-26 2014-05-01 Mannkind Corporation Inhalable influenza vaccine compositions and methods
EP3587404B1 (en) 2013-03-15 2022-07-13 MannKind Corporation Microcrystalline diketopiperazine compositions, methods for preparation and use thereof
EP2983697B1 (en) 2013-04-03 2018-10-31 Sanofi Treatment of diabetes mellitus by long acting formulations of insulins
MX375448B (es) 2013-07-18 2025-03-06 Mannkind Corp Composiciones farmacéuticas en polvo seco estables al calor y métodos.
EP3030294B1 (en) 2013-08-05 2020-10-07 MannKind Corporation Insufflation apparatus
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
WO2016001185A1 (en) * 2014-07-02 2016-01-07 Novo Nordisk A/S Dosage regimen for the treatment of diabetes
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
PE20171622A1 (es) 2014-12-12 2017-11-02 Sanofi Aventis Deutschland Formulacion de relacion fija de insulina glargina/lixisenatida
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患之治療
WO2017108943A1 (en) * 2015-12-23 2017-06-29 Sanofi-Aventis Deutschland Gmbh Cardiac metabolic effect of lantus
WO2018096164A1 (en) * 2016-11-28 2018-05-31 Novo Nordisk A/S Insulin degludec for treating diabetes
MA46890A (fr) * 2016-11-28 2021-04-28 Novo Nordisk As Insuline degludec pour l'amélioration du contrôle glycémique et la réduction des complications du diabète aigu et à long terme
WO2018096162A1 (en) * 2016-11-28 2018-05-31 Novo Nordisk A/S Insulin degludec in cardiovascular conditions
US11366189B2 (en) * 2020-09-25 2022-06-21 Uih America, Inc. Systems and methods for magnetic resonance imaging
CN119833121B (zh) * 2025-01-09 2025-10-24 南通大学 一种糖尿病症状自动检测系统

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5354331A (en) 1992-07-15 1994-10-11 Schachar Ronald A Treatment of presbyopia and other eye disorders
DE69826286T2 (de) * 1997-06-27 2005-11-24 Fujisawa Pharmaceutical Co., Ltd. Derivate mit einem aromatischen ring
CO5271699A1 (es) * 2000-01-24 2003-04-30 Pfizer Prod Inc Procedimiento para el tratamiento de cardiomiopatia utilizando inhibidores de la glucogeno fosforilasa
NZ522036A (en) * 2000-04-19 2004-04-30 Borody Thomas J Compositions and therapies for hyperlipidaemia-associated disorders
MXPA03003733A (es) * 2000-10-26 2004-10-15 Fournier Lab Ireland Ltd Combinacion de fenofibrato y coenzima q10 para el tratamiento de la disfuncion endotelial.

Similar Documents

Publication Publication Date Title
JP2006515625A5 (https=)
CA2512820A1 (en) Long acting insulin for reducing cardiovascular morbidity and mortality in prediabetic patients and patients with type 2 diabetes
Regnante et al. Clinical characteristics and four-year outcomes of patients in the Rhode Island Takotsubo Cardiomyopathy Registry
Gore et al. The 10-year post-trial follow-up of the United Kingdom Prospective Diabetes Study (UKPDS): cardiovascular observations in context
Nau et al. Glycemic control in hospitalized patients not in intensive care: beyond sliding-scale insulin
JP2020502150A5 (https=)
JP2020502151A5 (https=)
JP2020502140A5 (https=)
Cottin et al. Glucose insulin potassium infusion improves systolic function in patients with chronic ischemic cardiomyopathy
Karmakar et al. Recent advancements on novel approaches of insulin delivery
Doró et al. Seasonality in the incidence of type 2 diabetes: a population-based study
Korlakunta et al. Transient left ventricular apical ballooning: a novel heart syndrome
Malmberg et al. Insulin treatment post myocardial infarction: the DIGAMI study
Bonadei et al. Ivabradine during cardiogenic shock: A clinical case and review of the literature
Shan et al. Reversible left ventricular dyssynchrony and dysfunction resulting from right ventricular pre-excitation
Chakrabarti et al. Admission hyperglycemia and acute myocardial infarction: outcomes and potential therapies for diabetics and nondiabetics
Aronow Editorials Editorial on management of diabetes mellitus with coronary artery disease
Meyers et al. Takotsubo cardiomyopathy in association with DKA in a blind pump patient
Kochanowski et al. Biventricular takotsubo cardiomyopathy in an elderly woman with uncontrolled type 2 diabetes: the biphasic echocardiographic and clinical pattern
Fazio et al. Transient mid-ventricular dyskinesia: a variant of Takotsubo syndrome
Bălan Chronotherapy of hypertension: when can be as important as with what
Shiza TYPE 1 KOUNIS SYNDROME: ALLERGIC VASOSPASTIC CARDIAC EVENT TRIGGERED BY CIPROFLOXACIN
Schofield et al. Telehealth management of heart failure improves cardiac remodeling
CN1039785C (zh) 松针的新用途
Civera et al. Acute coronary syndrome presenting as syncope